CLOSE

Specials

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

Skip to: Curated Story Group 1
lifesciencesreview
US
EUROPE
APAC
CANADA
  • US
    • US
    • EUROPE
    • APAC
    • CANADA
    • LATAM
  • Home
  • Contributors
  • News
  • Conferences
  • Newsletter
  • Whitepapers
  • Magazine
×
#

Life Science Review Weekly Brief

Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Life Science Review

Subscribe

loading

Thank you for Subscribing to Life Science Review Weekly Brief

  • Home
  • News

Recommended picks

Humans Have Kept Evolving New Genes

Humans Have Kept Evolving New Genes

The Necessity of Next-Generation Sequencing

The Necessity of Next-Generation...

Technologies to have an impact on science this year.

Technologies to have an impact on...

A rise in DNA Sequencing Market is expected in coming years

A rise in DNA Sequencing Market is...

Data analysis for next-generation sequencing worth USD1.2 billion by 2026 - Cloud-based platforms emerging as preferred solutions

Data analysis for next-generation...

Portuguese Start-Up Kicks Off Genetic Test That Detects Diseases In Babies Using Saliva

Portuguese Start-Up Kicks Off Genetic...

Element Biosciences Strikes Multiple Partnerships to Integrate Sequencer With Existing NGS Products

Element Biosciences Strikes Multiple...

Technologies that will revolutionize cancer care

Technologies that will revolutionize...

Humans Have Kept Evolving New Genes

Humans Have Kept Evolving New Genes

The Necessity of Next-Generation Sequencing

The Necessity of Next-Generation...

Technologies to have an impact on science this year.

Technologies to have an impact on...

A rise in DNA Sequencing Market is expected in coming years

A rise in DNA Sequencing Market is...

Data analysis for next-generation sequencing worth USD1.2 billion by 2026 - Cloud-based platforms emerging as preferred solutions

Data analysis for next-generation...

Portuguese Start-Up Kicks Off Genetic Test That Detects Diseases In Babies Using Saliva

Portuguese Start-Up Kicks Off Genetic...

Element Biosciences Strikes Multiple Partnerships to Integrate Sequencer With Existing NGS Products

Element Biosciences Strikes Multiple...

Technologies that will revolutionize cancer care

Technologies that will revolutionize...

The Next-Generation Sequencing Revolution Revitalizes Clinical Metagenomics

Life Sciences Review | Wednesday, July 13, 2022
Tweet

 Selected researchers in the Asia-Pacific region describe how they are using metagenomics to enhance infectious disease surveillance.


FREMONT, CA: Lower respiratory infections and diarrheal diseases are the leading causes of death worldwide, with 4.1 million fatalities in 2019. The current COVID-19 pandemic is just another reminder of the need to systematically survey for early symptoms of infectious disease outbreaks using advanced scientific technologies.


Culture (media and agar), serological detection of pathogen-associated antibodies, and PCR detection of microbial genetic materials (DNA or RNA) are all examples of traditional microbial diagnostics procedures. However, these methods have a significant coverage constraint. Only a fraction of infections may be detected using appropriate culture conditions, antigens, or primers. Microbial culture, for example, may not be sensitive enough to capture low microbial loads or suited for microbes that cannot be cultivated outside of the human body.


To address these issues, metagenomic techniques that profile all DNA or RNA in a patient sample, including the complete microbiome and the human host genome or transcriptome, are gaining popularity. Though Metagenomic approaches are not a brand new concept, they have been utilised to characterize environmental and forensic samples extensively.


Metagenomic investigations are currently carried out utilising next-generation sequencing technologies, which have higher throughput than microarray approaches. For an extensive examination of clinical samples, NGS allows millions to billions of reads to be generated every run. NGS is also credited with cost reductions. Because of these benefits, NGS has become the most widely used metagenomics approach, and it has been crucial in discovering the reasons for antibiotic resistance and infectious disease epidemics.


The following example of a typical metagenomic next-generation sequencing workflow showcases how the total nucleic acid extraction of DNA and RNA is performed. The reverse transcription of RNA into the corresponding cDNA is then performed. Then, using tools such as those from Illumina and Oxford Nanopore Technologies, DNA and cDNA materials are sequenced and assigned to their reference genomes to establish which microbial populations are present and in what relative proportions. Magnetic beads can be employed in a capture probe enrichment stage to improve sensitivity when detecting infections in low quantities.


When compared to mNGS, the molecular PCR diagnostics assay is very cost-effective and quick. mNGS, on the other hand, allows a far broader spectrum of pathogens, such as viruses, bacteria, fungi, and parasites, to be detected directly from clinical samples using unique DNA or RNA sequences. Importantly, mNGS data can be used with other characterisation approaches, such as RNA sequencing of human host responses, to better understand disease progression and pathogen and treatment responses.


Weekly Brief

loading
TOP VENDORS
Top 10 Emerging Next Generation Sequencing Companies In Europe- 2022
TOP VENDORS
Top 10 Next-Generation Sequencing Solutions Companies in Europe – 2022
TOP VENDORS
Top 10 Emerging Next Generation Sequencing Companies In Europe- 2022
TOP VENDORS
Top 10 Next-Generation Sequencing Solutions Companies in Europe – 2022
> <
  • Regulatory Services 2023

    Top Vendors

    Current Issue
  • Clinical Lab Equipment 2023

    Top Vendors

    Current Issue
  • Proteomics 2022

    Top Vendors

    Current Issue
  • Regulatory Services 2023

    Top Vendors

    Current Issue
  • Clinical Lab Equipment 2023

    Top Vendors

    Current Issue
  • Proteomics 2022

    Top Vendors

    Current Issue

Read Also

Hepion Pharmaceuticals to Get a Total of $ 3.2 Million in Non-Dilutive Financing

Benefits that Medical Writing Offers

Antibodies: Immunoglobulin Isotypes

Life Science Consulting Services Trends

Rani Therapeutics and Celltrion Partner to Develop Oral Monoclonal Antibodies

ProPhase Labs Acquires BE-Smart Esophageal Pre-Cancer Screening Test

The Influence of Pharmaceutical Distributors on U.S. Drug Expenditures

Tips to Improve Medical Writing

Loading...

Copyright © 2023 Life Sciences Review . All rights reserved. |  Subscribe |  About Us follow on linkedin

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://www.lifesciencesreview.com/news/the-nextgeneration-sequencing-revolution-revitalizes-clinical-metagenomics-nwid-747.html